Gadolinium Agents Banned in Other Countries Except the U.S.
Europe along with other countries decided they would ban 13 linear gadolinium contrast agents used for MRIs and MRAs. The ban comes after many European agencies became concerned about gadolinium retaining in the brain. However, the United States hasn’t made any efforts to remove these dangerous contrast dyes from the market. About Gadolinium Gadolinium is a
Read More
Gadolinium Chelation: A Long Unsuccessful Cure
After someone realizes that gadolinium has not left the body, doctors suggest chelation. IV or oral chelation is a long and expensive process. However, as many have realized, it usually does nothing to remove gadolinium. Then, symptoms continue for the rest of the patient’s life. About Gadolinium Gadolinium is a chemical element carrying the atomic number 64
Read More
Your Gadolinium Deposition Disease Attorney
Persons who have suffered from MRI contrast side effects may be entitled to compensation through filing gadolinium lawsuits against the manufacturers. When Chuck Norris’s wife filed three gadolinium lawsuits in 2017, the public learned about the threat of gadolinium deposition disease. Many have experienced chronic pain, kidney damage, skin problems, and cognitive loss as a
Read More
History of Gadolinium Toxicity
Last year, 60 experts from around the world gathered at a workshop during the National Institutes of Health. They aimed to bridge the gap between ongoing concern of gadolinium toxicity and the medical community denying it. About Gadolinium Gadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a
Read More
Doctors Slam Excess MRI Scans Contributing To Gadolinium Toxicity
In 1984, the FDA approved magnetic resonance imaging (MRI) scanners, and the medical community was thrilled. These amazing machines offered an internal view of the human body. This made it easier to diagnose disease, injuries, and physical abnormalities. However, today, this amazing discovery is now a multibillion-dollar industry. These scans earn big profit margins and
Read More
MRI Centers Not Distributing Gadolinium Warning Pamphlet
Last May, the FDA approved a new patient medication guide. The pamphlet warns patients of potential dangers of the contrast dye. However, many facilities are not distributing the gadolinium warning pamphlet. How will patients know the dangers of gadolinium if doctors won’t distribute the warnings? About Gadolinium Gadolinium is a chemical element carrying the atomic number
Read More
New Study Uncovers Multiple Gadolinium Retention Symptoms
The Journal of Nephrology and Hypertension has published a new study concerning gadolinium-based contrast agents. Researchers were shocked to discover the large amounts of gadolinium retention symptoms that plagued those in the study. Contrary to the current medical opinion, these symptoms happen regardless of kidney function. About Gadolinium Gadolinium is a chemical element carrying the
Read More
Germans Pinpoint Gadolinium Brain Connection
German researchers have discovered how gadolinium-based contrast agents (GBCAs) enter the brain via the glymphatic pathway. In past studies, researchers often overlook and misinterpret the pathway. They emphasize this discovery has important clinical implications. About Gadolinium Gadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a group of
Read More
Results of Gadolinium Clinical Trial Expected Soon
Currently, researchers are performing a clinical trial examining gadolinium efficacy along with possible side effects. GE Healthcare will publish the preliminary findings at the end of the month. However, the study isn’t scheduled for completion until 2019. About Gadolinium Gadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a
Read More
New Gadolinium Study Shows Long Retention Rates
Recently, researchers published a follow-up study on gadolinium retention from Gadolinium-based Contrast Agents (GBCAs) administered for contrast-enhanced MRIs. The study followed nearly 200 people after receiving the contrast agent. Medical professionals believe that gadolinium exits the body within a few hours and sometimes days. However, the researchers found this is not to case. In fact,
Read More